CLINICAL_TRIALS
trial_result
· 2017-03-21
Clinical Trial Update: Study of Safety of Foradil in Patients With Persistent Asthma [Phase 4]
Summary
A Phase 4 safety study of Foradil (formoterol) in patients with persistent asthma was terminated. Results have been posted (2017-03-21).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Persistent Asthma | Phase 4 | Status: TERMINATED | Results posted: 2017-03-21